Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding

被引:157
作者
Koch, Michael [1 ]
Camp, Simon [2 ]
Collen, Trevor [2 ]
Avila, David [3 ]
Salomonsen, Jan [3 ]
Wallny, Hans-Joachim [3 ]
van Hateren, Andrew [2 ]
Hunt, Lawrence [2 ]
Jacob, Jansen P. [2 ]
Johnston, Fiona [2 ]
Marston, Denise A. [2 ]
Shaw, Iain [2 ]
Dunbar, P. Rod [4 ]
Cerundolo, Vincenzo [4 ]
Jones, E. Yvonne [1 ]
Kaufman, Jim [2 ,3 ,5 ,6 ]
机构
[1] Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England
[2] Inst Anim Hlth, Compton RG20 7NN, Berks, England
[3] Basel Inst Immunol, CH-4005 Basel, Switzerland
[4] Univ Oxford, Weatherall Inst Mol Med, Tumor Immunol Unit, Oxford OX3 9DS, England
[5] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[6] Dept Vet Med, Cambridge CB3 0ES, England
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.immuni.2007.11.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known about the structure of major histocompatibility complex (MHC) molecules outside of mammals. Only one class I molecule in the chicken MHC is highly expressed, leading to strong genetic associations with infectious pathogens. Here, we report two structures of the MHC class I molecule BF2*2101 from the B21 haplotype, which is known to confer resistance to Marek's disease caused by an oncogenic herpesvirus. The binding groove has an unusually large central cavity, which confers substantial conformational flexibility to the crucial residue Arg9, allowing remodeling of key peptide-binding sites. The coupled variation of anchor residues from the peptide, utilizing a charge-transfer system unprecedented in MHC molecules, allows peptides with conspicuously different sequences to be bound. This promiscuous binding extends our understanding of ways in which MHC class I molecules can present peptides to the immune system and might explain the resistance of the B21 haplotype to Marek's disease.
引用
收藏
页码:885 / 899
页数:15
相关论文
共 72 条
  • [1] Apostolopoulos Vasso, 2004, Expert Rev Vaccines, V3, P151, DOI 10.1586/14760584.3.2.151
  • [3] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [4] Barrow A, 1999, ACTA VIROL, V43, P90
  • [5] MAREKS-DISEASE - EFFECTS OF B-HISTOCOMPATIBILITY ALLOALLELES IN RESISTANT AND SUSCEPTIBLE CHICKEN LINES
    BRILES, WE
    STONE, HA
    COLE, RK
    [J]. SCIENCE, 1977, 195 (4274) : 193 - 195
  • [6] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921
  • [7] The 1.4 Å crystal structure of kumamolysin:: A thermostable serine-carboxyl-type proteinase
    Comellas-Bigler, M
    Fuentes-Prior, P
    Maskos, K
    Huber, R
    Oyama, H
    Uchida, K
    Dunn, BM
    Oda, K
    Bode, W
    [J]. STRUCTURE, 2002, 10 (06) : 865 - 876
  • [8] Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
    Dunbar, PR
    Ogg, GS
    Chen, J
    Rust, N
    van der Bruggen, P
    Cerundolo, V
    [J]. CURRENT BIOLOGY, 1998, 8 (07) : 413 - 416
  • [9] Further additions to MolScript version 1.4, including reading and contouring of electron-density maps
    Esnouf, RM
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1999, 55 : 938 - 940
  • [10] Flajnik MF, 1999, J IMMUNOL, V163, P3826